The Twenty-third World Health Assembly, Recalling resolution WHA22.50; Having examined the report of the Director-General on the quality control of drugs Noting that several Member States already have or are taking steps towards implementing a control system and certification scheme in line with the recommendations in resolution WHA22.50; and Stressing the need for further information from Member States on the implications at the national level of the adoption of the recommendations, 1. CONGRATULATES the Director-General on his report; 2. INVITES Member States to inform the Director-General of steps taken with respect to resolution WHA22.50 and their possible administrative implications, including suggestions for improvement of the texts on Good Practices in the Manufacture and Quality Control of Drugs and the certification scheme;1 and 3. REQUESTS the Director-General to continue to review in the light of information obtained the requirements for Good Practices in the Manufacture and Quality Control of Drugs and the certification scheme, and to report to the Twenty-fourth World Health Assembly. Handb. Res., 10th ed., 1.10.4.1 Fifteenth plenary meeting, 21 May 1970 (Committee A9 fourth report)